CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab

Neurol Clin Pract. 2019 Jun;9(3):273-276. doi: 10.1212/CPJ.0000000000000639.

Authors

Murtaza Khan¹, Douglas E Ney¹, Bette K Kleinschmidt-DeMasters¹, Lindsay Horton¹, Enrique Alvarez¹, Amanda L Piquet¹

Affiliation

¹ Department of Neurology (MK, DEN, BKK-D, LH, EA, ALP), Department of Neurosurgery (DEN, BKK-D), and Department of Pathology (BKK-D), University of Colorado, Aurora, CO.

No abstract available

Publication types

Case Reports